Concepedia

Bernard Calandra

BC

14

Publications

4.8K

Citations

14

H-Index

1994

Active since

Affiliations

Sanofi (France)(Current)

Bernard Calandra is an author at Sanofi (France) specializing in medicine, pharmacology, and cannabinoids.

Top concepts

Publications per year

1994–2000

14

Publications

14

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

Murielle Rinaldi‐Carmona, Francis Barth, Michel Héaulme et al. · FEBS Letters · 1994 · 1.7K citations · Full text

, , +18

SR 144528, the First Potent and Selective Antagonist of the CB2 Cannabinoid Receptor

M Rinaldi-Carmona, Francis Barth, J Millan et al. · Journal of Pharmacology and Experimental Therapeutics · 1998 · 704 citations · Full text

Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1

Monsif Bouaboula, Caroline Poinot‐Chazel, B. Bourrié et al. · Biochemical Journal · 1995 · 537 citations · Full text

A Selective Inverse Agonist for Central Cannabinoid Receptor Inhibits Mitogen-activated Protein Kinase Activation Stimulated by Insulin or Insulin-like Growth Factor 1

Monsif Bouaboula, Sylvie Perrachon, Laura Milligan et al. · Journal of Biological Chemistry · 1997 · 459 citations · Full text

An Amino-terminal Variant of the Central Cannabinoid Receptor Resulting from Alternative Splicing

David Shire, Christine Carillon, Mourad Kaghad et al. · Journal of Biological Chemistry · 1995 · 322 citations · Full text

Rows per page

1–5 of 14